Page last updated: 2024-08-23

tobramycin and Morbid Obesity

tobramycin has been researched along with Morbid Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brüggemann, RJM; Knibbe, CAJ; Mouton, JW; Smit, C; van Dongen, HPA; Wasmann, RE; Wiezer, MJ	1

Other Studies

1 other study(ies) available for tobramycin and Morbid Obesity

Article	Year
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study. Pharmaceutical research, 2019, May-30, Volume: 36, Issue:8 Topics: Adult; Anti-Bacterial Agents; Bariatric Surgery; Body Weight; Computer Simulation; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Tobramycin	2019

Article

Year

Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.

Pharmaceutical research, 2019, May-30, Volume: 36, Issue:8

Topics: Adult; Anti-Bacterial Agents; Bariatric Surgery; Body Weight; Computer Simulation; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Tobramycin

2019